Waren Acquisitions

Waren Acquisitions is a specialized investment vehicle established to facilitate the acquisition of Vectura Group from Philip Morris International (PMI). Following the acquisition in 2024, the company oversees Vectura's operations as a leading contract development and manufacturing organization (CDMO) focused on inhaled drug delivery. Vectura provides end-to-end services for the development of dry powder inhalers, pressurized metered-dose inhalers, and nebulized therapies. The company's portfolio includes both proprietary technology platforms and a range of partnered products for respiratory conditions such as asthma and COPD. Waren Acquisitions aims to reposition Vectura as a pure-play healthcare entity, distancing it from its previous tobacco-industry ownership.